Open
14.24 0.92
24h
Min
13.86
Max
14.27
Income | 68M 55M |
---|---|
Sales | 11M 26M |
P/E Sector Avg | 60.125 35.739 |
Profit margin | 209.334 |
Employees | 97 |
EBITDA | 87M 75M |
Recommendations | Buy |
---|---|
12 Months Forecast | +38.7% upside |
Next Earnings | 11 lis 2025 |
---|
Market Cap | 157M 727M |
---|---|
Previous open | 13.32 |
Previous close | 14.24 |
By Trading Central
Confidence
Bullish Evidence
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Price change
By TipRanks
12 Months Forecast
Average 20 USD 38.7%
High 28 USD
Low 13 USD
Based on 6 Wall Street analysts offering 12 month price targets forTheravance Biopharma Inc - Dist in the last 3 months.
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$